International Stem Cell CORP Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
International Stem Cell CORP quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • International Stem Cell CORP Operating Income (Loss) for the quarter ending September 30, 2024 was -$90K, a 7.22% increase year-over-year.
  • International Stem Cell CORP Operating Income (Loss) for the twelve months ending September 30, 2024 was -$543K, a 205% decline year-over-year.
  • International Stem Cell CORP annual Operating Income (Loss) for 2023 was -$663K, a 262% decline from 2022.
  • International Stem Cell CORP annual Operating Income (Loss) for 2022 was -$183K, a 90.5% increase from 2021.
  • International Stem Cell CORP annual Operating Income (Loss) for 2021 was -$1.92M, a 31.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$543K -$90K +$7K +7.22% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$550K $149K +$293K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$843K -$178K -$180K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$663K -$424K -$485K -795% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$178K -$97K +$203K +67.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$381K -$144K -$175K -565% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$206K $2K* -$23K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$183K $61K +$386K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$569K -$300K +$323K +51.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$892K $31K +$437K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$1.33M $25K +$592K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$1.92M -$325K +$408K +55.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$2.33M -$623K +$175K +21.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$2.5M -$406K +$426K +51.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$2.93M -$567K -$112K -24.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$2.82M -$733K +$1.75M +70.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$4.57M -$798K +$15K +1.85% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$4.59M -$832K +$109K +11.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$4.69M -$455K +$1.03M +69.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$5.73M -$2.49M -$1.23M -97.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$4.5M -$813K -$150K -22.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$4.35M -$941K -$574K -156% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$3.78M -$1.49M -$304K -25.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-19
Q4 2018 -$3.47M -$1.26M +$665K +34.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-06-01
Q3 2018 -$4.14M -$663K +$307K +31.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$4.45M -$367K +$635K +63.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-27
Q1 2018 -$5.08M -$1.19M -$139K -13.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$4.94M -$1.92M -$751K -64% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-15
Q3 2017 -$4.19M -$970K +$292K +23.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$4.48M -$1M +$247K +19.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$4.73M -$1.05M +$121K +10.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$4.85M -$1.17M -$134K -12.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-09
Q3 2016 -$4.72M -$1.26M -$640K -103% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$4.08M -$1.25M -$312K -33.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$3.77M -$1.17M +$799K +40.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$4.56M -$1.04M +$1.3M +55.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$5.86M -$622K +$1.41M +69.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$7.28M -$937K +$1.31M +58.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$8.58M -$1.97M +$99K +4.79% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$8.68M -$2.34M -$398K -20.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$8.28M -$2.03M -$331K -19.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$7.95M -$2.24M -$53K -2.42% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$7.9M -$2.07M -$352K -20.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$7.55M -$1.94M +$651K +25.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 -$8.2M -$1.7M +$377K +18.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$8.57M -$2.19M +$235K +9.69% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$8.81M -$1.71M +$1.01M +37% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$9.82M -$2.59M +$315K +10.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-17
Q3 2012 -$10.1M -$2.08M +$1.04M +33.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$11.2M -$2.43M +$433K +15.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$11.6M -$2.72M -$250K -10.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$11.4M -$2.91M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-26
Q3 2011 -$3.12M -$182K -6.19% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$2.86M -$5.6K -0.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 -$2.47M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 -$2.94M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$2.85M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.